Eplerenone in resistant hypertension with previous spironolactone intolerance;Eplerenona en hipertensión arterial resistente con intolerancia previa a espironolactona

Medicina Clinica

Volumn 132, Issue 19, 2009, Pages 756-757

  Antonio Costa, José ^a   Rodilla, Enrique ^a   Pérez Lahiguera, Francisco ^a   María Pascual, José ^a,b  

^a HOSPITAL DE SAGUNTO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPLERENONE; SPIRONOLACTONE;

ARTERIAL PRESSURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; ENDOCRINE DISEASE; HUMAN; HYPERTENSION; LETTER;

ALDOSTERONE ANTAGONISTS; DRUG RESISTANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPIRONOLACTONE;

EID: 67649526421     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.11.015     Document Type: Letter

References (8)

1. Guidelines Committee 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Journal of Hypertension 25 2007 1105 1187
2. R. Marín, A. de la Sierra, P. Armario, C. Campo, J.R. Banegas, M. Gorostidi Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005 Med Clin (Barc) 125 2005 24 34
3. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, and R.D. Toto Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 510 526
4. K.F. Croom, and C.M. Perry Eplerenone: a review of its use in essential hypertension Am J Cardiovasc Drugs 5 2005 51 69
5. E. Rodilla, J.A. Costa, F. Pérez-Lahiguera, C. González, and J.M. Pascual Respuesta antihipertensiva a la espironolactona en pacientes con hipertensión arterial refractaria Med Clin (Barc) 131 2008 406 411
6. E. Rodilla, J.A. Costa, F. Pérez-Lahiguera, S. Mares, C. González, and J.M. Pascual Uso de espironolactona o doxazosina en la hipertensión arterial refractaria Rev Esp Cardiol 62 2009 15 22
7. J. Ouzan, C. Perault, A.M. Lincoff, E. Carré, and M. Mertes The role of spironolactone in the treatment of patients with refractory hypertension Am J Hypertens 15 2002 333 339
8. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321 Epub 2003 Mar 31. Erratum in: N Engl J Med. 2003;348:2271